CTRI/2017/10/010145已完成2 期
â??A Pilot Evaluation of Safety and Efficacy of an Ayurvedic Formulation (AYUSH 64) for accelerating the recovery in cases of Influenza like Illness.
Central Council for Research in Ayurvedic Sciences Ministry of AYUSH GoI0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of either sex age between age 18- 65 years.
- •2.Voluntarily signed informed consents to participate in the study.
- •3.Clinically diagnosed cases of influenza like illness, having Axillary temperature >=38ºC and with at least two constitutional symptoms (headache, chills, myalgia or fatigue) and one respiratory symptom (cough, sore throat or coryza). Illness onset has to be within 36 hours.
排除标准
- •1.Aged <18 or >65yrs.
- •2.Cases of bronchitis, pneumonia, pleural effusion, interstitial lesions, etc.
- •3.Routine blood WBC is greater than the upper limit of normal; (WBC >11.0x109/L) and lesser than normal (WBC <4.0x109/L) or NEUT. >=75%
- •4.Patients coughing purulent sputum or with suppurative tonsillitis.
- •5.Patients with uncontrolled diabetes, COPD, hepatic insufficiency (ALT or AST 2 times above normal or higher); renal insufficiency (serum creatinine more than the upper lab value); chronic congestive heart failure, psychiatric diseases.
- •6.Have already taken antiviral drugs (amantadine, rimantadine, zanamivir and oseltamivir phosphate, etc.) or related traditional medicine after the onset /before the screening.
- •7.Women in pregnancy or lactation period, women of childbearing age with plan of a pregnancy.
- •8.Patients who are immune-compromised, such as malignant tumor, organ or bone marrow transplantation and AIDS, or taking immunosuppressant in last 3 months.
- •9.With dubious or confirmed alcohol and drug abuse history.
- •10.Suffered from acute respiratory infection, otitis media or sinusitis 2 weeks before.
- •11.Having vaccination of a seasonal or new influenza A (H1N1) vaccine 6 months before.
- •12.Other reasons that researchers think not fitting to participate in the study.
研究者
相似试验
招募中
不适用
A safety and efficacy pilot study on the use of a continuous distraction spring in addition to growing rod surgery in children with congenital, neuromuscular or idiopathic spinal deformities.ScolioseSpinal growth deformitiesscoliosisNL-OMON56121niversitair Medisch Centrum Utrecht160
已完成
不适用
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944NL-OMON43676Vrije Universiteit Medisch Centrum33
进行中（未招募）
不适用
A Pilot Study to Examine the Safety and Efficacy of Posterior Juxtascleral Triamcinolone acetonide administration, in addition to Visudyne photoynamic therapy for predominantly Classic Choroidal Neovascularisation secondary to age related Macular degeneration: an open label randomised active controlled trial. - Efficacy of Juxtascleral Triamcinolone acetonide as an adjunct to PDTClassic or predominantly classic age related macular degenerationEUCTR2005-002466-11-GBKing's College Hospital80
进行中（未招募）
Unknown
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue DiseasesISRCTN13586698ouna Aesthetics75
进行中（未招募）
不适用
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volumeISRCTN72858148Sinclair Pharma68